Ahmet IRDEM

Ahmet IRDEM


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2019 in Medicina
Verified
Journal Article
Open access
PDF file
FAFatih Aygun
Fatih Aygun
FVFatih Varol
Fatih Varol
CDCANSU DURAK
CANSU DURAK
MPMey Talip Petmezci
Mey Talip Petmezci
AKAlper Kacar
Alper Kacar
HÇHalit Çam
Halit Çam
Background and objective: Severe sepsis and septic shock are life-threatening organ dysfunctions and causes of death in critically ill patients. The therapeutic goal of the management of sepsis is restoring balance to the immune system and fluid balance. Continuous renal replacement therapy (CRRT) is recommended in septic patients, and it may improve outcomes in patients with severe sepsis or septic shock. Therapeutic plasma exchange (TPE) is another extracorporeal procedure that can improve organ function by decreasing inflammatory and anti-fibrinolytic mediators and correcting haemostasis by replenishing anticoagulant proteins. However, research about sepsis and CRRT and TPE in children has been insufficient and incomplete. Therefore, we investigated the reliability and efficacy of extracorporeal therapies in paediatric patients with severe sepsis or septic shock. Materials and methods: We performed a multicentre retrospective study using data from all patients aged <18 years who were admitted to two paediatric intensive care units. Demographic data and reason for hospitalization were recorded. In addition, vital signs, haemogram parameters, and biochemistry results were recorded at 0 h and after 24 h of CRRT. Patients were compared according to whether they underwent CRRT or TPE; mortality between the two treatment groups was also compared. Results: Between January 2014 and April 2019, 168 septic patients were enrolled in the present study. Of them, 47 (27.9%) patients underwent CRRT and 24 underwent TPE. In patients with severe sepsis, the requirement for CRRT was statistically associated with mortality (p < 0.001). In contrast, the requirement for TPE was not associated with mortality (p = 0.124). Conclusion: Our findings revealed that the requirement for CRRT in patients with severe sepsis is predictive of increased mortality. CRRT and TPE can be useful techniques in critically ill children with severe sepsis. However, our results did not show a decrease of mortality with CRRT and TPE.

1 February 2013 in Acta Cardiologica
Verified
Journal Article
Closed access
OBOsman Baspinar
Osman Baspinar
AIAhmet IRDEM
Ahmet IRDEM
MKMetin Kilinc
Metin Kilinc
Background Certain medical devices used to treat congenital cardiac lesions in the cardiac catheterization laboratory are used on an off -label and non-routine basis. This article discusses the non-routine use of Amplatzer medical devices. Methods In a retrospective study, from-11-2006 to-12-2011, Amplatzer devices used in our paediatric cardiology ward were reviewed. Results Children (n = 436) were catheterized to close their defects (438 defects) using Amplatzer devices. The mean age and body weight of the patients were 5.87 ± 4.2 years and 20.8 ± 13.6 kg. On-label devices were used for 421 patients (96.1%) and off -label devices for 17 patients (3.9%). The off -label use indications and used devices were the Amplatzer septal occluder (aortopulmonary window closure), the muscular ventricular septal occluder (perimembranous ventricular septal defect occlusion, patent ductus arteriosus occlusion, and right pulmonary artery to left atrium fi stulous connection closure), the vascular plug (coronary fi stula occlusion, left ventricle pseudoaneurysm occlusion, atypical patent ductus arteriosus occlusion, and anomalous pulmonary venous drainage occlusion), and the ductal occluder (ventricular septal defect occlusion). These devices were successfully implanted in exclusively extraordinary, diffi cult, or extreme cases. Conclusions The use of a medical device outside of its approved purpose is commonly referred to as “off -label use”. This study showed that the issue of off -label, non-routine use of devices exists in paediatric cardiology. Furthermore, the percutaneous closure of defects with non-routine Amplatzer devices is safe and eff ective, with a high success rate and a high follow-up term outcome.

28 June 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
YTYelda Türkmenoğlu
Yelda Türkmenoğlu
EGElif Güney
Elif Güney
DBDiğdem BEZEN
Diğdem BEZEN
AIAhmet IRDEM
Ahmet IRDEM
BEBiray Ertürk
Biray Ertürk
HDHasan Dursun
Hasan Dursun
Familial Mediterranean fever (FMF), the most common autoinflammatory disease in children, is characterized by recurrent febrile episodes. FMF is known to progress with chronic inflammation, particularly during attack periods. This study aimed to investigate the relationship of S100A12, an inflammatory marker, with attacks and inflammatory events in FMF patients. The study included 57 patients diagnosed with FMF, 43 in an attack-free period and 14 in an attack period, and 31 healthy children as the control group. Only white blood cell (WBC) count, C-reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), and S100A12 level were analyzed in the control group. In addition, serum amyloid A (SAA), and fibrinogen levels were measured, and a mutation analysis was performed in the patient group. The results were compared among the attack-free period, acute attack FMF and control groups. The mean age of patients and control group was 10 (2.5 - 18) and 9.5 (2.5 - 16) years, respectively. The CRP (p = 0.001), S100A12 (p = 0.003) and ESR (p= 0.001) values differed significantly between the FMF and control groups. S100A12 level (p = 0.027), WBC count (p = 0.003), CRP level (p = 0.0001), ESR (p = 0.004), and fibrinogen level (p = 0.001) differed significantly between the acute attack and attack-free period groups. SAA level (p = 0.05), ESR (p = 0.001), fibrinogen level (p = 0.001), WBC count (p = 0.001), and S100A12 level (p = 0.027) were higher in M694V homozygous FMF patients than in other FMF patients. Patients with FMF had higher S100A12 levels than the control group, while the mean S100A12 concentration was higher in acute attack period patients than in attack-free period patients. S100A12 level might be an important indicator in the monitoring of chronic inflammation in patients with FMF.

1 January 2014 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Closed access
AIAhmet IRDEM
Ahmet IRDEM
The risk of fatal pulmonary and systemic thromboembolism is high in patients with dilated cardiomyopathy with cardiac thrombus. This study was planned to reveal the efficacy of antiaggregant therapy in patients with low left ventricular systolic ejection fraction (LVEF). The present study retrospectively reviewed the files of 83 cases (42 males, 41 females) with dilated cardiomyopathy who were followed between June 2004 and December 2011. Intracardiac thrombus was detected in five (6%) cases; of these five patients, dilated cardiomyopathy was idiopathic in four and secondary to chronic renal failure in one. The cases were followed for a mean of 33.6±35.6 months (3 days-168 months). Mean LVEF on transthoracic echocardiography was found as 35.2±2.7% (32-38%) for the cases with intracardiac thrombus, whereas it was 34.7±11.0% (10-55%) for the cases without intracardiac thrombus. No statistically significant difference was found between the groups (p=0.910). Cases with LVEF ≤30% were routinely receiving acetylsalicylic acid at antiaggregant dose. We think that prophylactic antithrombotic/antiaggregant therapy should be started at the time of diagnosis even in patients with LVEF >30%, as thrombus development was seen in cases with LVEF >30% without any antiaggregant therapy.

21 March 2014 in Surgery Today
Verified
Journal Article
Closed access
PDF file
AIAhmet IRDEM
Ahmet IRDEM
OBOsman Baspinar
Osman Baspinar
GGGokhan Gokaslan
Gokhan Gokaslan

1 May 2014
Verified
Journal Article
Closed access
OBOsman Baspinar
Osman Baspinar
MKMehmet Kervancioglu
Mehmet Kervancioglu
SKSenem Koruk
Senem Koruk
MKMetin Kilinc
Metin Kilinc
AIAhmet IRDEM
Ahmet IRDEM